The ubiquitin proteasome pathway from bench to bedside.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 220-225

  Orlowski, Robert Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; CYSTEINE PROTEINASE INHIBITOR; PROTEASOME; PYRAZINE DERIVATIVE; UBIQUITIN;

APOPTOSIS; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BORONIC ACIDS; CLINICAL TRIALS AS TOPIC; CYSTEINE PROTEINASE INHIBITORS; HUMANS; LYMPHOMA, NON-HODGKIN; MULTIPLE MYELOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; UBIQUITIN;

EID: 33846694742     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.220     Document Type: Article

References (0)